Medtronic Plc [NYSE: MDT] stock went on a downward path that fall over -1.64% on Tuesday, amounting to a one-week price decrease of less than -2.59%.
Over the last 12 months, MDT stock rose by 8.39%. The one-year Medtronic Plc stock forecast points to a potential upside of 5.23. The average equity rating for MDT stock is currently 2.38, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $113.67 billion, with 1.31 billion shares outstanding and 1.28 billion shares in the current float. Compared to the average trading volume of 6.35M shares, MDT stock reached a trading volume of 7011384 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Medtronic Plc [MDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $93.52 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 2.38. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Medtronic Plc shares, keeping their opinion on the stock as Perform, with their previous recommendation back on August 21, 2024. While these analysts kept the previous recommendation, UBS raised their target price from $76 to $90. The new note on the price target was released on August 15, 2024, representing the official price target for Medtronic Plc stock. Previously, the target price had yet another drop from $100 to $85, while Stifel kept a Hold rating on MDT stock.
The Average True Range (ATR) for Medtronic Plc is set at 1.53, with the Price to Sales ratio for MDT stock in the period of the last 12 months amounting to 3.49. The Price to Book ratio for the last quarter was 2.37, with the Price to Cash per share for the same quarter was set at 6.12. Price to Free Cash Flow for MDT in the course of the last twelve months was 22.09 with Quick ratio for the last quarter at 1.61.
MDT Stock Performance Analysis:
Medtronic Plc [MDT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.59. With this latest performance, MDT shares gained by 4.76% in over the last four-week period, additionally plugging by 5.94% over the last 6 months – not to mention a rise of 8.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDT stock in for the last two-week period is set at 55.57, with the RSI for the last a single of trading hit 47.82, and the three-weeks RSI is set at 58.20 for Medtronic Plc [MDT]. The present Moving Average for the last 50 days of trading for this stock 83.86, while it was recorded at 89.82 for the last single week of trading, and 83.26 for the last 200 days.
Insight into Medtronic Plc Fundamentals:
Medtronic Plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.61 and a Current Ratio set at 2.13.
MDT Stock EPS
With the latest financial reports released by the company, Medtronic Plc posted 1.25/share EPS, while the average EPS was predicted by analysts to be reported at 1.18/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.07. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic Plc go to 5.51%.
Medtronic Plc [MDT] Institutonal Ownership Details
There are presently around $85.95%, or 86.17%% of MDT stock, in the hands of institutional investors. The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 126.61 million shares, which is approximately 9.5358%. BLACKROCK INC., holding 111.89 million shares of the stock with an approximate value of $$8.81 billion in MDT stocks shares; and BLACKROCK INC., currently with $$4.78 billion in MDT stock with ownership which is approximately 4.535%.
